BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20738984)

  • 61. Efficacy, tolerability, impact on quality of life and sebostatic activity of three topical preparations for the treatment of mild to moderate facial acne vulgaris.
    Stinco G; Piccirillo F; Valent F; Errichetti E; DI Meo N; Trevisan G; Patrone P
    G Ital Dermatol Venereol; 2016 Jun; 151(3):230-8. PubMed ID: 25236322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
    Zeichner JA; Wong V; Linkner RV; Haddican M
    J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
    Webster G; Thiboutot DM; Chen DM; Merikle E
    Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
    Weiss JW; Shavin J; Davis M
    Clin Ther; 2002 Oct; 24(10):1706-17. PubMed ID: 12462298
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician.
    Kircik L
    Cutis; 2009 Nov; 84(5 Suppl):5-11. PubMed ID: 19999187
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
    Dhawan SS; Gwazdauskas J
    Cutis; 2013 Feb; 91(2):99-104. PubMed ID: 23513559
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 69. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implications of the BEST study.
    Shavin J; Weiss J
    Cutis; 2003 Feb; 71(2 Suppl):35-6. PubMed ID: 12630673
    [No Abstract]   [Full Text] [Related]  

  • 71. Clindoxyl gel for the treatment of acne vulgaris.
    Tan JK
    Skin Therapy Lett; 2002 May; 7(5):1-2. PubMed ID: 12223978
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.
    Tucker SB; Tausend R; Cochran R; Flannigan SA
    Br J Dermatol; 1984 Apr; 110(4):487-92. PubMed ID: 6231942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The BEST study: evaluating efficacy by selected demographic subsets.
    Fernandez-Obregon A; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S; Gold M; Nasir A; Vamvakias G
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Topical therapy for acne.
    Russell JJ
    Am Fam Physician; 2000 Jan; 61(2):357-66. PubMed ID: 10670502
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
    Amar L; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progressive macular hypomelanosis.
    Elmariah SB; Kundu RV
    J Drugs Dermatol; 2011 May; 10(5):502-6. PubMed ID: 21533296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
    Bikowski J; Del Rosso JQ
    J Drugs Dermatol; 2008 Jun; 7(6):590-5. PubMed ID: 18561594
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acne therapy.
    White GM
    Adv Dermatol; 1999; 14():29-58; discussion 59. PubMed ID: 10643494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.